We combined cellular models for BRCA1/2 inactivation with xenograft tumor growth in mice to demonstrate that exogenous acetaldehyde effectively and selectively reduced the survival of BRCA1/2‐deficient cells and tumors including those that are PARP inhibitor‐resistant. The gene discussed is BRCA1; the disease is neoplasm.